Newbio Trading Corp.

Industry Notes

Summaries of published research, prepared for industry readers. These notes describe what individual studies measured and reported. They are not product claims, and nothing here is advice for the care of a person or an animal.

• Prospective cohort Human health Annals of Hepatology · 2026-09-19

  Physical activity, gut microbiota and steatotic liver disease: a five-year cohort adds a metabolite to the picture

  A five-year cohort links moderate-to-vigorous activity to lower steatotic liver disease risk, and identifies a risk-associated genus and a branched-chain amino acid that track with it.

• Narrative review Human health Gut Microbes · 2026-09-18

  The gut–kidney axis in stone formation: a review that maps mechanisms, not outcomes

  A review maps the mechanisms connecting gut microbiota to urinary stone formation, and stops short of outcome data — the interventional literature it points toward has not been done.

• Narrative review Human health Gut Microbes · 2026-09-17

  Gut–bone axis in osteoporosis: a mechanism review, with the endpoint gap left open

  Four mechanistic pathways for probiotics in bone metabolism, reported against bone mineral density — a surrogate. Fracture incidence, the endpoint that matters, is not reported.

• Randomised controlled trial Companion animal Veterinary Dermatology · 2026-09-17

  A second-generation selective JAK1 inhibitor in canine atopic dermatitis: placebo-controlled, 61 dogs, 28 days

  A placebo-controlled trial of a selective JAK1 inhibitor in 61 client-owned dogs over 28 days. The comparator is placebo, not current standard of care.

• Narrative review Infant nutrition Trends in Microbiology · 2026-09-17

  Micronutrient–microbiota interactions in infancy: context-dependence as the finding

  Micronutrient effects on the developing infant microbiota vary by developmental stage, nutritional status, intestinal location and environmental exposure. Context-dependence is the finding.